A carregar...
ACTR-11. OVERALL SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH OPTUNE® CORRELATES WITH COMPLIANCE: CONSISTENCY ACROSS STUDIES
Optune® is an FDA-approved portable medical device that delivers continuous treatment with Tumor-Treating Fields (TTFields) to the supratentorial region of the brain and is indicated for the treatment of newly diagnosed glioblastoma multiforme (GBM) in combination with temozolomide and for recurrent...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691920/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|